Managing bladder health in children with myelomeningocele
Urological Outcomes of Proactive Management of Children With Myelomeningocele
This study is testing whether early treatments for bladder health can help children with myelomeningocele avoid kidney problems and improve their bladder function.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT06301802 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the proactive management of children diagnosed with myelomeningocele, a severe form of spina bifida. It emphasizes the importance of early interventions such as clean intermittent catheterization (CIC) and anticholinergic medications to prevent renal damage associated with neuropathic bladder. A multidisciplinary team approach is utilized, involving various specialists to ensure comprehensive care. The study aims to evaluate the outcomes of these proactive measures in improving bladder function and reducing the risk of chronic kidney disease.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with myelomeningocele who are attending Assiut University Urology Hospital.
Not a fit: Patients with associated urological congenital anomalies, such as posterior urethral valves or bladder exstrophy, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve bladder health and kidney function in children with myelomeningocele.
How similar studies have performed: While the proactive management of myelomeningocele is a recognized approach, the specific outcomes of this study may provide novel insights into its effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients with myelomeningocele attending Assiut university urology hospital. Exclusion Criteria: * Associated other urological congenital anomalies (e.g., PUV or bladder exstrophy)
Where this trial is running
Assiut
- Assiut university hospital — Assiut, Egypt (Recruiting)
Study contacts
- Study coordinator: Islam Mahmoud, DR
- Email: doctorislam672@gmail.com
- Phone: 00201090088672
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.